首页> 外文期刊>Molecular Carcinogenesis >CSE1L Links cAMP/PKA and Ras/ERK Pathways and Regulates the Expressions and Phosphorylations of ERK1/2, CREB, and MITF in Melanoma Cells
【24h】

CSE1L Links cAMP/PKA and Ras/ERK Pathways and Regulates the Expressions and Phosphorylations of ERK1/2, CREB, and MITF in Melanoma Cells

机译:CSE1L链接cAMP / PKA和Ras / ERK通路,并调节黑色素瘤细胞中ERK1 / 2,CREB和MITF的表达和磷酸化

获取原文
获取原文并翻译 | 示例
           

摘要

The Ras/ERK (extracellular signal-regulated protein kinase) and cAMP/PKA (protein kinase A) pathways are essential for the transcriptional activities of CREB (cAMP response element binding protein) and MITF (microphthalmia-associated transcription factor) in melanogenesis and the progression of melanoma. However, the interaction between Ras/ERK and cAMP/PKA pathways in the melanogenesis and progression of melanoma is not fully known. Here, we report that CSE1L (chromosome segregation 1-like protein) regulates cAMP/PKA-induced CREB and MITF expressions as well as Ras-induced ERK1/2 phosphorylation. IBMX, a cAMP/PKA activator, treatment induced CSE1L phosphorylation and augmented Ras-induced ERK1/2 phosphorylation. CSE1L knockdown by CSE1L shRNA expression vectors inhibited Ras-induced ERK1/2 phosphorylation and melanogenesis in melanoma cells. CSE1L overexpression increased phospho-CREB expression; CSE1L knockdown also inhibited Ras-induced phospho-CREB, MITF, and tyrosinase expressions, regardless of the presence of IBMX. This study identifies CSE1L links and controls the Ras/ERK and cAMP/PKA pathways in the melanogenesis of melanoma cells. Melanomas frequently develop drug resistance via paradoxical activation of Ras/Raf/MEK/ERK or alternatively activated Ras/ERK and cAMP/PKA pathways. Thus CSE1L may be a potential target for treating melanomas that harbor Ras mutations or are resistant to drugs targeting Raf/MEK/ERK. (C) 2015 Wiley Periodicals, Inc.
机译:Ras / ERK(细胞外信号调节蛋白激酶)和cAMP / PKA(蛋白激酶A)途径对于CREB(cAMP响应元件结合蛋白)和MITF(小眼症相关转录因子)在黑素生成和细胞凋亡中的转录活性至关重要。黑色素瘤进展。但是,尚不完全了解Ras / ERK和cAMP / PKA途径在黑色素瘤的黑色素形成和发展中的相互作用。在这里,我们报告CSE1L(染色体分离1样蛋白)调节cAMP / PKA诱导的CREB和MITF表达以及Ras诱导的ERK1 / 2磷酸化。 IBMX,一种cAMP / PKA激活剂,可治疗CSE1L磷酸化并增强Ras诱导的ERK1 / 2磷酸化。 CSE1L shRNA表达载体对CSE1L的抑制作用抑制了Ras诱导的黑色素瘤细胞ERK1 / 2磷酸化和黑色素生成。 CSE1L过表达增加磷酸-CREB表达;不管是否存在IBMX,CSE1L敲低还抑制Ras诱导的磷酸化CREB,MITF和酪氨酸酶的表达。这项研究确定了CSE1L链接并控制黑色素瘤细胞黑色素生成中的Ras / ERK和cAMP / PKA途径。黑色素瘤经常通过反常激活Ras / Raf / MEK / ERK或交替激活的Ras / ERK和cAMP / PKA途径而产生耐药性。因此,CSE1L可能是治疗具有Ras突变或对靶向Raf / MEK / ERK的药物具有抗性的黑色素瘤的潜在靶标。 (C)2015威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号